• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction.

作者信息

Abelin Jennifer G, Harjanto Dewi, Malloy Matthew, Suri Prerna, Colson Tyler, Goulding Scott P, Creech Amanda L, Serrano Lia R, Nasir Gibran, Nasrullah Yusuf, McGann Christopher D, Velez Diana, Ting Ying S, Poran Asaf, Rothenberg Daniel A, Chhangawala Sagar, Rubinsteyn Alex, Hammerbacher Jeff, Gaynor Richard B, Fritsch Edward F, Greshock Joel, Oslund Rob C, Barthelme Dominik, Addona Terri A, Arieta Christina M, Rooney Michael S

出版信息

Immunity. 2021 Feb 9;54(2):388. doi: 10.1016/j.immuni.2020.12.005.

DOI:10.1016/j.immuni.2020.12.005
PMID:33567264
Abstract
摘要

相似文献

1
Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction.利用质谱法定义HLA-II配体加工和结合规则可增强癌症表位预测。
Immunity. 2021 Feb 9;54(2):388. doi: 10.1016/j.immuni.2020.12.005.
2
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.利用质谱法定义 HLA-II 配体加工和结合规则可增强癌症抗原预测。
Immunity. 2019 Oct 15;51(4):766-779.e17. doi: 10.1016/j.immuni.2019.08.012. Epub 2019 Sep 5.
3
Footprints of antigen processing boost MHC class II natural ligand predictions.抗原加工足迹增强 MHC Ⅱ类天然配体预测。
Genome Med. 2018 Nov 16;10(1):84. doi: 10.1186/s13073-018-0594-6.
4
Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data.通过整合洗脱配体和肽亲和力数据来提高肽-MHC Ⅱ类相互作用预测。
Immunogenetics. 2019 Jul;71(7):445-454. doi: 10.1007/s00251-019-01122-z. Epub 2019 Jun 10.
5
Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy.有序和无序蛋白区域中的表位分布-第 A 部分。T 细胞表位频率、亲和力和亲水性。
J Immunol Methods. 2014 Apr;406:83-103. doi: 10.1016/j.jim.2014.02.012. Epub 2014 Mar 12.
6
Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry.利用质谱法绘制肿瘤人类白细胞抗原(HLA)配体组图谱。
Immunology. 2018 Jul;154(3):331-345. doi: 10.1111/imm.12936. Epub 2018 May 8.
7
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction.单等位基因细胞中HLA相关肽组的质谱分析可实现更准确的表位预测。
Immunity. 2017 Feb 21;46(2):315-326. doi: 10.1016/j.immuni.2017.02.007.
8
Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes.用于预测 HLA Ⅱ类分子限制性 T 细胞表位的广泛方案的开发与验证
J Immunol Methods. 2015 Jul;422:28-34. doi: 10.1016/j.jim.2015.03.022. Epub 2015 Apr 7.
9
An HLA-B27 Homodimer Specific Antibody Recognizes a Discontinuous Mixed-Disulfide Epitope as Identified by Affinity-Mass Spectrometry.一种 HLA-B27 同型二聚体特异性抗体通过亲和质谱鉴定识别出一个不连续的混合二硫键表位。
J Am Soc Mass Spectrom. 2016 Jun;27(6):1105-12. doi: 10.1007/s13361-016-1361-9. Epub 2016 Apr 11.
10
Predicted MHC peptide binding promiscuity explains MHC class I 'hotspots' of antigen presentation defined by mass spectrometry eluted ligand data.预测的 MHC 肽结合多态性解释了通过质谱洗脱配体数据定义的 MHC I 类抗原呈递的“热点”。
Immunology. 2018 Jul;154(3):407-417. doi: 10.1111/imm.12905. Epub 2018 Mar 8.

引用本文的文献

1
Immunoprevention of non-viral cancers: challenges and strategies for early intervention.非病毒性癌症的免疫预防:早期干预的挑战与策略
Cancer Cell Int. 2025 May 28;25(1):196. doi: 10.1186/s12935-025-03817-8.
2
Exploration of metastasis-related signatures in osteosarcoma based on tumor microenvironment by integrated bioinformatic analysis.基于肿瘤微环境通过综合生物信息学分析探索骨肉瘤中转移相关特征
Heliyon. 2024 Dec 19;11(1):e41358. doi: 10.1016/j.heliyon.2024.e41358. eCollection 2025 Jan 15.
3
ConvNeXt-MHC: improving MHC-peptide affinity prediction by structure-derived degenerate coding and the ConvNeXt model.
ConvNeXt-MHC:通过结构衍生的简并编码和 ConvNeXt 模型提高 MHC-肽亲和力预测。
Brief Bioinform. 2024 Mar 27;25(3). doi: 10.1093/bib/bbae133.
4
The SysteMHC Atlas v2.0, an updated resource for mass spectrometry-based immunopeptidomics.SysteMHC Atlas v2.0,一个基于质谱的免疫肽组学更新资源。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1062-D1071. doi: 10.1093/nar/gkad1068.
5
Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation.癌症新抗原:预测、优先级排序及验证面临的挑战与未来方向
Front Oncol. 2022 Mar 3;12:836821. doi: 10.3389/fonc.2022.836821. eCollection 2022.